Do you lose more weight on a higher dose of Wegovy?

Do you lose more weight on a higher dose of Wegovy (semaglutide)? Generally, yes. Higher doses of both the Wegovy pill and pen tend to produce greater weight loss, but how much more isn’t always straightforward. Here’s what the clinical trials show, and what it could mean for your treatment. 

Yes, you tend to lose more weight on a higher dose of Wegovy, though results vary from person to person.

In adults with overweight or obesity, the standard 2.4 mg maintenance dose produced an average weight loss of 14.9% over 68 weeks, compared to 2.4% on placebo. This trial was published in 2021, when 2.4 mg was the highest Wegovy dose available. 

In March 2026, the US Food and Drug Administration (FDA) approved a higher dose of 7.2 mg. In a 72-week study, people taking 7.2 mg lost an average of 18.7% of their body weight, compared with 15.6% with 2.4 mg and 3.9% with a placebo. Around one in three people on the higher dose — also known as Wegovy HD — achieved at least 25% weight loss.

That said, the incremental weight loss gains with each dose increase tend to get smaller the higher you go — a pattern typical of GLP-1 medications. In other words, tripling the dose of Wegovy from 2.4 mg to 7.2 mg does not triple the weight loss — it increases it by about three percentage points, on average.

See if you qualify

Wegovy comes in two forms, each with its own step-up schedule that eases side effects like nausea and other gastrointestinal (GI) symptoms. 

• The once-weekly injection climbs every four weeks to a 2.4 mg maintenance dose.

• The once-daily pill increases every 30 days to a 25 mg maintenance dose. 

After at least four weeks at 2.4 mg, your healthcare provider may increase the dose to 7.2 mg (i.e. the higher Wegovy HD injection) if more weight loss is needed. If the 2.4 mg injection or 25 mg tablet causes bothersome side effects, your provider may recommend switching to the 1.7 mg injection as maintenance treatment.

Talk with your healthcare provider about the right dose for you, as it should be one that works well and your body can tolerate.

Most people without diabetes lose roughly 15%--19% of their body weight on Wegovy, depending on the dose, how long they take it, and whether it's paired with lifestyle changes like a balanced diet and increased activity. For someone starting at 250 pounds, that's roughly 37-47 pounds.

The once-daily pill produces similar results. In clinical trials, people taking the 25 mg tablet lost an average of 13.6% of their body weight over 64 weeks.

The loss also builds gradually rather than arriving all at once. It's usually modest in the first month, picks up speed with each dose increase, and continues over several months before leveling off, often around 60–70 weeks in. 

These figures come from trials where people also followed a reduced-calorie diet and stayed active, so your own pace and total may look different.

Weight can return if you stop treatment, so the goal is a dose you can comfortably stay on.

Dose increases follow a set schedule: the injection steps up every four weeks, and the pill every 30 days. Your healthcare provider may suggest staying at a lower dose longer if side effects are difficult to manage, or if you're already losing weight at a pace that's working for you. You don't automatically need to reach the highest dose to see results. Some people do well at lower doses throughout their treatment.

Signs your current dose may be working:

• Steady, consistent weight loss week over week

• Reduced hunger and fewer food cravings

• Side effects that are mild and are settling down over time

• Finding it easier to maintain healthier eating habits

Chasing the highest dose isn't always the best strategy, though. Research suggests semaglutide drives weight loss by reducing fat while largely preserving muscle function. Strength training and getting enough protein can help support that as you lose weight. (Not sure how much protein to eat? Our free calculator can help.) 

If your weight loss has plateaued after several months at your maintenance dose, speak with your healthcare provider about your options. Your dosage should be discussed with your healthcare provider, not handled on your own.

The higher 7.2 mg dose applies only to the injection and may be worth discussing for people who haven't reached their goals at 2.4 mg. However, it is associated with a higher rate of GI side effects and dysesthesia (altered skin sensations).

The highest approved dose of Wegovy is 7.2 mg per week, following FDA approval in March 2026. Before this, 2.4 mg was the maximum maintenance dose.

That 7.2 mg figure refers specifically to the highest dose of the Wegovy injection. The once-daily tablet is dosed differently, topping out at 25 mg, so the two aren't directly comparable on a milligram-for-milligram basis.

Wegovy HD (7.2 mg dose) is for people who haven't achieved sufficient weight loss after at least four weeks at 2.4 mg. It's not a starting point. You need to complete the standard escalation schedule first before moving up to 7.2 mg.

Based on clinical data from the higher dose:

• More weight loss: people lost an average of 18.7% over 72 weeks (20.7% among those who stayed on treatment throughout), compared to 15.6% at 2.4 mg in the same trial. 

• Bigger responders: about 1 in 3 people achieved 25% or greater weight loss.

• Altered skin sensations: around 22% of people at 7.2 mg reported dysesthesia (skin sensations like burning or tingling), compared to 6% at 2.4 mg.

• Serious side effects: these were reported at similar or lower rates than at 2.4 mg.

More people experience nausea, vomiting, and other GI symptoms at the higher dose, though these tend to be mild to moderate and ease over the weeks following a dose increase.

Check your coverage for FDA-approved GLP-1s—for free

Check for free

You do tend to lose more weight on a higher dose of Wegovy, but more isn't always better for everyone.

• Clinical trials show a clear jump in average weight loss between the 2.4 mg and 7.2 mg doses, but the gap is modest at about three additional percentage points.

• Reaching the maximum dose isn't a requirement. Steady progress at a lower dose, especially alongside healthy lifestyle changes, can be just as meaningful.

• Every four weeks, your healthcare provider will assess whether moving up to the next dose makes sense for your body. If side effects are hard to manage, they may delay the next increase to give your body more time to adjust and make it easier to stay on treatment.

• Going higher does increase the likelihood of GI side effects, though most tend to be mild and settle down after a few weeks at each new dose.

Everyone's response to Wegovy is different, and the right dose is one that delivers steady progress while staying manageable.